Castleman's disease: Systematic analysis of 416 patients from the literature

Oncologist

Volumn 16, Issue 9, 2011, Pages 1316-1324

  Talat, Nadia ^a   Schulte, Klaus Martin ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Castleman's disease; HIV; Lymph node; Viral infection

Indexed keywords

AGE DISTRIBUTION; ANGIOFOLLICULAR LYMPH NODE HYPERPLASIA; ARTICLE; DISEASE ASSOCIATION; DISEASE FREE SURVIVAL; ENDOCRINE DISEASE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KAPOSI SARCOMA; LYMPHOMA; MONOCLONAL IMMUNOGLOBULINEMIA; PEMPHIGUS; PLASMA CELL; POLYNEUROPATHY; PREDICTION; PRIORITY JOURNAL; SEX DIFFERENCE; SYSTEMATIC REVIEW; VASCULAR DISEASE;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; GIANT LYMPH NODE HYPERPLASIA; HUMANS; MALE; MIDDLE AGED;

EID: 80053189058     PISSN: 10837159     EISSN: 1549490X     Source Type: Journal    
DOI: 10.1634/theoncologist.2011-0075     Document Type: Article

References (35)

1. Castleman B, Towne VW. Case records of the Massachusetts General Hospital; weekly clinicopathological exercises; founded by Richard C. Cabot. N Engl J Med 1954;251(10):396-400.
2. Castleman B, Iverson L, Menendez VP. Localized mediastinal lymphnode hyperplasia resembling thymoma. Cancer 1956;9:822-830.
3. Stebbing J, Pantanowitz L, Dayyani F et al. HIV-associated multicentric Castleman's disease. Am J Hematol 2008;83:498-503.
4. Schulte KM, Talat N. Castleman's disease-a two compartment model of HHV8 infection. Nat Rev Clin Oncol 2010;7:533-543.
5. Oksenhendler E. HIV-associated multicentric Castleman disease. Curr Opin HIV AIDS 2009;4:16-21.
6. Dispenzieri A. Castleman disease. Cancer Treat Res 2008;142:293-330.
7. Dham A, Peterson BA. Castleman disease. Curr Opin Hematol 2007;14: 354-359.
8. Casper C. The aetiology and management of Castleman diseaseat 50 years: Translating pathophysiology topatient care.Br JHaematol 2005;129:3-17.
9. Ablashi DV, Chatlynne LG, Whitman JE et al. Spectrum of Kaposi's sarcoma-associated herpesvirus, or human herpesvirus 8, diseases. Clin Mi-crobiol Rev 2002;15:439-464.
10. Hengge UR, Ruzicka T, Tyring SK et al. Update on Kaposi's sarcoma and other HHV8 associated diseases. Part 2: Pathogenesis, Castleman's disease, and pleural effusion lymphoma. Lancet Infect Dis 2002;2:344-352.
11. Keller AR, Hochholzer L, Castleman B. Hyaline-vascular and plasma-cell types of giant lymph node hyperplasia of the mediastinum and other locations. Cancer 1972;29:670-683.
12. Cronin DM, Warnke RA. Castleman disease: An update on classification and the spectrumof associated lesions. Adv Anat Pathol 2009;16:236-246.
13. Jongsma TE, Verburg RJ, Geelhoed-Duijvestijn PH. Castleman's disease: A rare lymphoproliferative disorder. Eur J Intern Med 2007;18:87-89.
14. Mylona EE, Baraboutis IG, Lekakis LJ et al. Multicentric Castleman's disease in HIV infection: A systematic review of the literature. AIDS Rev 2008;10:25-35.
15. Collins LS, Fowler A, Tong CY et al. Multicentric Castleman's disease in HIV infection. Int J STD AIDS 2006;17:19-24; quiz 25.
16. Dispenzieri A, Gertz MA. Treatment of Castleman's disease. Curr Treat Options Oncol 2005;6:255-266.
17. Casper C, Wald A. The use of antiviral drugs in the prevention and treatment of Kaposi sarcoma, multicentric Castleman disease and primary effusion lymphoma. Curr Top Microbiol Immunol 2007;312:289-307.
18. Simonelli C, Tedeschi R, Gloghini A et al. Plasma HHV-8 viral load in HHV-8-related lymphoproliferative disorders associated with HIV infection. J Med Virol 2009;81:888-896.
19. Oksenhendler E, Duarte M, Soulier J et al. Multicentric Castleman's disease in HIV infection: A clinical and pathological study of 20 patients. AIDS 1996;10:61-67.
20. Casquero A, Barroso A, Fernàndez Guerrero ML et al. Use of rituximab as a salvage therapy for HIV-associated multicentric Castleman disease. Ann Hematol 2006;85:185-187.
21. Bazeos A, Powles T, Stebbing J. HIV-associated Castleman's disease: From case reports to evidence. J HIV Ther 2007;12:61-62.
22. Powles T, Stebbing J, Montoto S et al. Rituximab as retreatment for ritux-imab pretreated HIV-associated multicentric Castleman disease. Blood 2007;110:4132-4133.
23. Weisenburger DD. Multicentric angiofollicular lymph node hyperplasia. Pathology of the spleen. Am J Surg Pathol 1988;12:176-181.
24. Ye B, Gao SG, Li W et al. A retrospective study of unicentric and multi-centric Castleman's disease: A report of 52 patients. Med Oncol 2010;27: 1171-1178.
25. Talat N, Belgaumkar AP, Schulte KM. Surgery in Castleman's disease: Systematic review of 404 published cases. Ann Surg, in press.
26. Roca B. Castleman's disease. A review. AIDS Rev 2009;11:3-7.
27. McClain KL, Natkunam Y, Swerdlow SH. Atypical cellular disorders. He-matology Am Soc Hematol Educ Program 2004:283-296.
28. Hsi ED. Castleman Disease. Hematopathology. Philadelphia: Churchill Livingstone Elsevier, 2007:150-155.
29. Dispenzieri A. POEMS syndrome. Blood Rev 2007;21:285-299.
30. Dupin N, Fisher C, Kellam P et al. Distribution of human herpesvirus-8 latently infected cells in Kaposi's sarcoma, multicentric Castleman's disease, and primary effusion lymphoma. Proc Natl Acad Sci USA 1999;96:4546-4551.
31. Meijs M, Mekkes J, van Noesel C et al. Paraneoplastic pemphigus associated with follicular dendritic cell sarcoma without Castleman's disease; treatment with rituximab. Int J Dermatol 2008;47:632-634.
32. Ascoli V, Sirianni MC, Mezzaroma I et al. Human herpesvirus-8 in lym-phomatous and nonlymphomatous body cavity effusions developing inKa-posi's sarcoma and multicentric Castleman's disease. Ann Diagn Pathol 1999;3:357-363.
33. Ascoli V, Signoretti S, Onetti-Muda A et al. Primary effusion lymphoma in HIV-infected patients with multicentric Castleman's disease. J Pathol 2001;193:200-209.
34. Cesarman E, Chang Y, Moore PS et al. Kaposi's sarcoma-associated her-pesvirus-like DNA sequences in AIDS-related body-cavity-based lympho-mas. N Engl J Med 1995;332:1186-1191.
35. Deloose ST, Smit LA, Pals FT et al. High incidence of Kaposi sarcoma-associated herpesvirus infection in HIV-related solid immunoblastic/plas-mablastic diffuse large B-cell lymphoma. Leukemia 2005;19:851-855.